10-K: Nortech Systems Reports Increased Revenue and Net Income in 2023 Annual Filing
Annual Results
Nortech Systems saw a 3.9% increase in net sales and a significant rise in net income for the year ended December 31, 2023, according to its annual report.
Summary
- Nortech Systems Incorporated reported a 3.9% increase in net sales, reaching $139.3 million in 2023, compared to $134.1 million in 2022.
- The company's net income significantly improved to $6.9 million in 2023, a substantial increase from $2.0 million in 2022.
- Gross profit also increased to $23.1 million in 2023 from $20.5 million in 2022, primarily due to price increases.
- The medical market accounted for over 50% of net sales, with the industrial and aerospace and defense markets also contributing to the growth.
- The company's 90-day order backlog was $35.1 million as of December 31, 2023, slightly down from $35.9 million at the end of 2022.
- Total order backlog decreased by 11.9% to $91.7 million as of December 31, 2023, compared to $104.1 million in 2022.
- Nortech Systems operates manufacturing facilities in the U.S., Mexico, and China, with a focus on complex electromedical and electromechanical products.
- The company's strategic focus includes expanding capabilities, improving supply chain management, and pursuing strategic opportunities like acquisitions and joint ventures.
Sentiment
Score: 7
Explanation: The document presents a positive outlook with significant improvements in net income and gross profit. However, there are some risks and challenges mentioned, such as customer concentration and supply chain issues, which temper the overall sentiment.
Positives
- The company experienced growth in all of its major markets: medical, industrial, and aerospace and defense.
- The increase in gross profit was primarily due to price increases implemented to address material and labor cost inflation.
- Nortech Systems successfully reversed a significant valuation allowance on deferred tax assets, positively impacting net income.
- The company secured a new credit agreement with Bank of America, providing financial flexibility.
- The company is focused on expanding its capabilities and footprint to meet changing market requirements.
Negatives
- The total order backlog decreased by 11.9% compared to the previous year.
- The company experienced a decrease in cash provided by operating activities, from $5.4 million in 2022 to $1.8 million in 2023.
- The company has a significant reliance on a small number of customers, with two customers accounting for 25.7% and 10.3% of net sales in 2023.
- The company faces risks related to supply chain disruptions, which could impact its ability to deliver products on time.
- The company is exposed to risks associated with operating in foreign countries, including economic and political volatility.
Risks
- The company is dependent on a small number of customers, and the loss of a major customer could adversely affect its business.
- Supply chain disruptions, component shortages, and increased material costs could impact production and profitability.
- The company faces competition from larger global manufacturers and OEM operations.
- Operating in foreign countries exposes the company to economic, political, and regulatory risks.
- Cybersecurity threats and breaches could disrupt operations and lead to financial losses.
- The company's reliance on information technology systems makes it vulnerable to system failures and interruptions.
- The company's restructuring efforts could lead to decreased employee morale and operational disruptions.
- The company's majority ownership structure could lead to actions that do not align with the interests of all shareholders.
- The company's investments in new technologies are inherently risky and may not be successful.
Future Outlook
The company believes that its existing financing arrangements, anticipated cash flows from operations, and cash on hand will be sufficient to satisfy its working capital needs, capital expenditures, and debt repayments for the next twelve months. The company continues to pursue strategic opportunities that may include acquisitions, mergers, and/or joint ventures with complementary companies to expand its service offering, advance its competitive edge, grow its customer base and increase net sales.
Management Comments
- The company's goal is to expand and diversify its customer base by focusing on sales and marketing efforts that fit its value-added service, early engagement design, and development strategy.
- The company continues to focus on lean manufacturing initiatives, quality and on-time delivery improvements to increase asset utilization, reduce lead times and provide competitive pricing.
- The company's strategic investments have positioned it to capitalize on growth opportunities in the medical markets and improve its competitiveness by expanding its global footprint.
- The company's industrial and defense markets are focused on improving asset utilization and profitability while transforming to a value-added, solution-sell business model that supports early engagement, design for manufacturability and rapid prototyping.
Industry Context
The company operates in the Electronic Manufacturing Services (EMS) industry, which is characterized by dynamic, high-tech, and regulated global electronics contract services. The company's focus on value-added services and strategic growth aligns with industry trends towards solution-based models and global supply chain management. The company's diversification across medical, aerospace and defense, and industrial markets helps mitigate the effects of economic fluctuations and competition.
Comparison to Industry Standards
- Nortech Systems competes with small closely held contract manufacturers, large global full-service contract manufacturers, company-owned in-house manufacturing facilities, and foreign contract manufacturers.
- The company believes that it is well-positioned to compete in the low to moderate volume, high mix customer demand segment, which is a good fit with its operations in the US, Mexico, and China.
- The company's focus on quality systems and certifications, such as ISO 9001, ISO 13485, and AS9100, aligns with industry standards for contract manufacturing.
- The company's investment in Restriction of Hazardous Substances (lead free) processing, equipment, plant capacity studies, people, enterprise resource planning systems, lean manufacturing and supply chain management techniques at its facilities is consistent with industry best practices.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Clawback Policy | The company adopted a clawback policy to recoup certain executive compensation in the event of an accounting restatement due to material noncompliance with financial reporting requirements. | 2023-11-30 | This policy is designed to comply with Section 10D of the Securities Exchange Act of 1934 and Nasdaq Listing Rule 5608, reinforcing the company's pay-for-performance compensation philosophy. |
Legal Proceedings
- The company is involved in ordinary, routine or regulatory legal proceedings incidental to the business.
Related Party Transactions
- The company had transactions with Abilitech Medical, Inc., where the Chairman is a minority owner, but has fully reserved the outstanding receivables and inventory due to Abilitech ceasing operations.
- The company has a relationship with Marpe Technologies, LTD, where the Chairman is a minority owner and board member, and has received a conditional grant from the BIRD Foundation.
Stakeholder Impact
- Shareholders will benefit from the increased net income and improved financial performance.
- Employees may benefit from the company's growth and strategic investments.
- Customers will benefit from the company's focus on quality, on-time delivery, and value-added services.
- Suppliers may benefit from the company's commitment to strong supplier partnerships and risk management tools.
Next Steps
- The company will continue to focus on expanding its capabilities and footprint to meet changing market requirements.
- The company will continue to pursue strategic opportunities that may include acquisitions, mergers, and/or joint ventures with complementary companies.
- The company will continue to focus on lean manufacturing initiatives, quality and on-time delivery improvements to increase asset utilization, reduce lead times and provide competitive pricing.
Key Dates
| Date | Description |
|---|---|
| 1990-12 | Nortech Systems Incorporated was organized. |
| 2017-05-03 | Shareholders approved the 2017 Stock Incentive Plan. |
| 2023-12-31 | End of the fiscal year for which the annual report is filed. |
| 2024-02-29 | Nortech Systems entered into a new credit agreement with Bank of America. |
| 2024-03-20 | Date of the independent auditor's report and the certifications of the CEO and CFO. |
| 2024-05-15 | Date of the Annual Meeting of Shareholders. |
Keywords
contract manufacturing, EMS, medical devices, aerospace and defense, industrial, supply chain, manufacturing, engineering services, financial results, net sales, net income, backlog
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.